Silence Therapeutics plc (SLN)

Silence Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	293	325	672	547	715	611
Market Cap Growth	-16.18%	-51.64%	22.71%	-23.44%	17.04%	-
Enterprise Value	191	152	600	448	612	549
Last Close Price	6.20	6.88	17.37	15.25	23.89	22.00
PS Ratio	11.41	7.51	21.23	25.28	42.53	81.67
PB Ratio	3.95	2.42	30.54	20.58	61.93	49.39
P/TBV Ratio	4.64	2.61	57.66	33.06	580.25	487.96
P/FCF Ratio	-	-	-	-	96.09	-
P/OCF Ratio	-	-	-	-	77.58	-
EV/Sales Ratio	7.39	3.52	18.97	20.67	36.40	73.34
EV/FCF Ratio	-	-	-	-	82.24	-
Debt / Equity Ratio	0.00	0.00	0.02	0.02	0.02	0.04
Debt / FCF Ratio	-	-	-	-	0.03	-
Asset Turnover	0.14	0.27	0.25	0.18	0.14	0.08
Quick Ratio	7.16	10.36	4.15	4.03	5.41	2.78
Current Ratio	7.69	11.14	4.62	4.41	5.69	2.99
Return on Equity (ROE)	-64.30%	-58.08%	-223.22%	-273.06%	-448.22%	-217.21%
Return on Assets (ROA)	-23.40%	-19.24%	-26.32%	-26.09%	-31.44%	-29.33%
Return on Capital (ROIC)	-43.50%	-39.61%	-132.49%	-170.42%	-317.04%	-126.58%
Return on Capital Employed (ROCE)	-54.10%	-26.70%	-54.00%	-49.70%	-56.50%	-51.30%
Earnings Yield	-22.04%	-13.95%	-8.07%	-9.20%	-7.46%	-7.27%
FCF Yield	-24.78%	-20.89%	-7.37%	-10.45%	1.04%	-2.52%
Buyback Yield / Dilution	-7.98%	-24.69%	-15.21%	-8.58%	-8.78%	-8.85%

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q